Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tesofensine/Metoprolol in Type 2 Diabetes Mellitus
NCT02737891Phase 2Completed
- Sponsor
- Saniona
- Start
- Apr 2016
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tesofensine in type 2 diabetes mellitus (T2DM), sponsored by Saniona. Started Apr 2016; status: completed.
02
Drugs
tesofensine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02737891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02737891.